Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for Anxiety and Depression in Bipolar Disorder
NCT05457465Phase 2Recruiting
- Sponsor
- McLean Hospital
- Start
- Jun 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in bipolar disorder (BD), sponsored by McLean Hospital. Started Jun 2023; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT05457465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05457465.